The mammalian Y chromosome encodes male-specific minor histocompatibility (H-Y) Ags that are recognized by female T cells in an MHC-restricted manner. Two human H-Y epitopes presented by HLA-A2 and HLA-B7, respectively, have been identified previously and both are derived from the SMCY gene. We previously isolated CD81 CTL clones that recognized a male-specific minor histocompatibility Ag presented by HLA-B8. In contrast to the SMCY-encoded H-Y epitopes, the B8/H-Y Ag was not presented by fibroblasts from male donors, suggesting that it was encoded by a novel gene. We now report that the HLA-B8-restricted H-Y epitope is defined by the octameric peptide LPHNHTDL corresponding to aa residues 566–573 of the human UTY protein. Transcription of ...
Rejection of male tissue grafts by genotypically identical female mice has been explained by the exi...
We have identified two peptides corresponding to the male-specific HY minor histocompatibility Ags p...
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a curative option for blood cancers...
Background: Stem-cell grafts between HLA-identical siblings are less likely to succeed when there is...
H-Y is a transplantation antigen that can lead to rejection of male organ and bone marrow grafts by ...
The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and...
Rejection of male tissue grafts by genotypically identical female mice has been explained by the exi...
The existence of transplantation antigens, in addition to those encoded by genes in the MHC, has bee...
Sex difference is an established risk factor for hematopoietic stem cell transplantation (HSCT)-rela...
AbstractThe products of minor histocompatibility (H ) loci are serious barriers to tissue transplant...
The products of minor histocompatibility (H) loci are serious barriers to tissue transplantation eve...
Background: Sex difference is an established risk factor for hematopoietic stem cell transplantation...
Cell-mediated immunity against polymorphic minor histocompatibility (mH) an-tigens is assumed to con...
In this report, we describe the use of novel mass spectrometry instrumentation to identify a male-sp...
Pluripotent stem cells are promising candidates for cell-based regenerative therapies. To avoid reje...
Rejection of male tissue grafts by genotypically identical female mice has been explained by the exi...
We have identified two peptides corresponding to the male-specific HY minor histocompatibility Ags p...
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a curative option for blood cancers...
Background: Stem-cell grafts between HLA-identical siblings are less likely to succeed when there is...
H-Y is a transplantation antigen that can lead to rejection of male organ and bone marrow grafts by ...
The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and...
Rejection of male tissue grafts by genotypically identical female mice has been explained by the exi...
The existence of transplantation antigens, in addition to those encoded by genes in the MHC, has bee...
Sex difference is an established risk factor for hematopoietic stem cell transplantation (HSCT)-rela...
AbstractThe products of minor histocompatibility (H ) loci are serious barriers to tissue transplant...
The products of minor histocompatibility (H) loci are serious barriers to tissue transplantation eve...
Background: Sex difference is an established risk factor for hematopoietic stem cell transplantation...
Cell-mediated immunity against polymorphic minor histocompatibility (mH) an-tigens is assumed to con...
In this report, we describe the use of novel mass spectrometry instrumentation to identify a male-sp...
Pluripotent stem cells are promising candidates for cell-based regenerative therapies. To avoid reje...
Rejection of male tissue grafts by genotypically identical female mice has been explained by the exi...
We have identified two peptides corresponding to the male-specific HY minor histocompatibility Ags p...
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a curative option for blood cancers...